This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Cellect Biotherapeutics Ltd.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Tal Almog: Innovator in Stem Cell Propagation
Introduction
Tal Almog is a notable inventor based in Kibbutz Nir Elyau, Israel. He has made significant contributions to the field of biotechnology, particularly in the area of stem cell research. His innovative methods have the potential to advance medical treatments and improve patient outcomes.
Latest Patents
Tal Almog holds a patent for "Methods for propagating mesenchymal stem cells (MSC) for use in transplantation." This patent outlines methods for propagating mesenchymal stem cells, specifically adipose-derived stem cells. The process involves incubating isolated cells obtained from a tissue or organ, including MSC, in a growth medium that contains an apoptosis-inducing agent, under specified conditions. Additionally, the patent provides an isolated cell population and kits for performing these methods. He has 1 patent to his name.
Career Highlights
Tal Almog is associated with Cellect Biotherapeutics Ltd., a company focused on developing innovative cell therapies. His work at the company emphasizes the importance of stem cell research and its applications in regenerative medicine. His contributions have been instrumental in advancing the company's mission to provide effective treatments for various medical conditions.
Collaborations
Tal Almog collaborates with Shai Yarkoni, a fellow innovator in the field. Their partnership highlights the importance of teamwork in driving forward scientific advancements and developing new technologies.
Conclusion
Tal Almog's work in stem cell propagation represents a significant advancement in biotechnology. His innovative methods and dedication to research continue to pave the way for future breakthroughs in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile